Pharmacy Drugs
Recent Posts
- EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-month Open Label Extension Of PRX-03140 For Alzheimer’s Disease
- Miriam Hospital Researcher Receives More Than $12 Million To Study Weight Control
- Novel HIV Drug To Be Studied In Cell Cultures And Patients
- ISCTM Meeting Discusses Clinical And Regulatory Aspects Of Using Adaptive Designs In Clinical Trials For Central Nervous System Drug Approvals
- Evaluation Of The Cost Effectiveness Of Implantable Blood Pressure Device
Random Posts
- AMA Reverses Stance on Medical Marijuana
- Lymphoma Patients Benefit From Exercise
- Pine Bark Shown To Improve Circulation, Swelling And Visual Acuity In Early Diabetic Retinopathy
- IKARIA(R) To In-License BioLineRx's BL-1040
- Medpace Therapeutic Expert, Charles Schmidt, MD, PhD To Present At The Pediatric Drug Development And Clinical Trials In Brussels, November 17-18
- Ask Your Pharmacist At CastleCourt Shopping Centre, UK
- Council Escalates Its Call For The Decriminalisation Of Dispensing Errors
- Denosumab Increases Bone Density, Cuts Fracture Risk In Prostate Cancer Survivors
- Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Industry Asked To Fund Government Purchasing, Australia
Incidence Of Contrast-Induced Nephropathy Reduced By Sodium Bicarbonate
Posted by: admin in Pharmacy Drugs on November 20th, 2009
A meta-analysis of 17 randomised controlled trials has shown that pre-procedural treatment with sodium bicarbonate based hydration is the optimal treatment strategy to prevent contrast-induced nephropathy (CIN). The research, published in the open access journal BMC Medicine, shows that although the benefit may have been overestimated by previous studies, sodium bicarbonate is clearly superior to normal saline.
Hitinder Gurm from the University of Michigan worked with a team of international researchers to study the results of trials featuring a total of 2633 people to assess the effectiveness of saline versus sodium bicarbonate for the prevention of CIN. According to Gurm, “Contrast agents are administered in millions of procedures annually worldwide. In the USA and Europe, contrast-induced nephropathy (CIN) is the third leading cause of acute renal failure in hospitalized patients, accounting for about 10% of hospital-acquired renal failure. Although CIN is generally limited to a transient decline of renal function, it cannot be regarded as a benign complication - as many as 30% of cases result in lasting kidney damage”.
The authors found that CIN occurred in 109 of the 1327 patients treated with sodium bicarbonate and in 175 of the 1306 patients who received normal saline. The number needed to prevent one case of CIN was 16. The exact mechanism of CIN is still unknown, but sodium bicarbonate is thought to prevent it by increasing the alkalinity of tubular fluid and thereby limiting free radical production. Gurm said, “Six studies monitored the degree of alkalinization and all but one found a significant increase. Interestingly this one study did not find a benefit of sodium bicarbonate. Therefore, it could be hypothesized that the bicarbonate should be dosed to achieve urinary alkalinization”.
Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis
Pascal Meier, Dennis T Ko, Akira Tamura, Umesh Tamhane and Hitinder S Gurm
BMC Medicine (in press) http://www.biomedcentral.com/bmcmed/
Source:
Graeme Baldwin
BioMed Central